Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Berlin
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Medical Equipment

Optiscan Imaging Ltd

+ Add to Watchlist

O5S:GR

0.042 EUR 0.001 2.33%

As of 02:08:05 ET on 04/01/2015.

Snapshot for Optiscan Imaging Ltd (O5S)

Open: 0.042 Day's Range: 0.042 - 0.042 Volume: 0
Previous Close: 0.043 52wk Range: 0.019 - 0.080 1-Yr Rtn: +31.25%

Stock Chart for O5S

No chart data available.
  • O5S:GR 0.042
  • 1M
  • 1Y
0.043
Interactive O5S Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for O5S

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. DAX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M EUR) 8.69
Shares Outstanding (M) 207.02
30 Day Average Volume 0
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/31/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for O5S

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for O5S

Optiscan Imaging Limited is a proprietor of patents which enable a confocal microscope to be miniaturized to the point where a confocal endomicroscope is made possible. The process enables living tissue to be examined non-invasively at a cellular level, opening up the possibilities for non-invasive disease monitoring and diagnosis.

Angus Matthew HoltChairmanBruce Richard AndrewCFO/Secretary
Peter Maxwell DelaneyDirector:Technology
More Company Profile & Key Executives for O5S

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil